
U.S. stock futures were higher on Wednesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Tuesday's lower close.
You can purchase shares of Liquidia (NASDAQ:LQDA) through any online brokerage.
Other companies in Liquidia’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Liquidia has a consensus price target of $42.81.
The stock price for Liquidia (NASDAQ: LQDA) is $45.43 last updated October 28, 2026 at 6:28 AM EDT.
There are no upcoming dividends for Liquidia.
Liquidia does not have any upcoming earnings scheduled.
There is no upcoming split for Liquidia.
Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary...